Monday, January 30, 2006
Study: Cardiac Drug Doubles Risk of Kidney Failure
Aprotinin -- a drug approved by the FDA, marketed internationally for the last 13 years, and given to an estimated one million surgery patients to limit bleeding -- has now been proven to double a patient's risk of kidney failure, and increase the risk of heart attack, heart failure, and stroke.Full Article
No such thing as a "good" drug imho.
